MAPT and Alzheimer disease: Interestingly, the impairment of autophagy-mediated proteostasis, which favors amyloid brain deposition and tau hyperphosphorylation [75], is associated with excessive and steady activation of the mammalian target of rapamycin (mTOR), which is abnormally elevated in AD patients [76].